Back to Search
Start Over
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8 + Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer.
- Source :
-
Frontiers in immunology [Front Immunol] 2021 May 26; Vol. 12, pp. 680973. Date of Electronic Publication: 2021 May 26 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- The immune infiltrate within tumors has proved to be very powerful in the prognostic stratification of patients and much attention is also being paid towards its predictive value. In this work we therefore aimed at clarifying the significance and impact of PD-L1 and PD-1 expression on the prognostic value of CD8 <superscript>+</superscript> tumor infiltrating lymphocytes (TILs) in a cohort of consecutive patients with primary resected non-small cell lung cancer (NSCLC). Tissue microarrays (TMA) were built using one representative formalin fixed paraffin embedded block for every case, with 5 cores for each block. TMA sections were stained with PD-L1 (clone SP263), PD-1 (clone NAT105) and CD8 (clone SP57). Number of CD8 <superscript>+</superscript> cells per mm <superscript>2</superscript>  were automatically counted; median, 25 <superscript>th</superscript> and 75 <superscript>th</superscript> percentiles of CD8 <superscript>+</superscript> cells were used as threshold for statistical clinical outcome analysis and evaluated in patients subgroups defined by expression of PD-L1 and PD-1 within tumors. We found an overall strong prognostic value of CD8 <superscript>+</superscript> cells in our cohort of 314 resected NSCLC, especially in PD-L1 negative tumors lacking PD-1 <superscript>+</superscript> TILs, and demonstrated that in PD-L1 positive tumors a higher density of CD8 <superscript>+</superscript> lymphocytes is necessary to improve the prognosis. Our data strengthen the concept of the importance of the assessment and quantification of the immune contexture in cancer and, similarly to what has been carried on in colorectal cancer, promote the efforts for the establishment of an Immunoscore for NSCLC for prognostic and possibly predictive purposes.<br />Competing Interests: FC is a consultant and member of the scientific advisory board of TRIBVN Healthcare, France. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2021 Munari, Marconi, Querzoli, Lunardi, Bertoglio, Ciompi, Tosadori, Eccher, Tumino, Quatrini, Vacca, Rossi, Cavazza, Martignoni, Brunelli, Netto, Moretta, Zamboni and Bogina.)
- Subjects :
- Aged
Aged, 80 and over
Biomarkers, Tumor
CD8-Positive T-Lymphocytes immunology
Carcinoma, Non-Small-Cell Lung diagnosis
Carcinoma, Non-Small-Cell Lung metabolism
Female
Gene Expression Regulation, Neoplastic
Humans
Kaplan-Meier Estimate
Lung Neoplasms diagnosis
Lung Neoplasms metabolism
Lymphocytes, Tumor-Infiltrating immunology
Male
Middle Aged
Neoplasm Grading
Neoplasm Staging
Prognosis
B7-H1 Antigen genetics
CD8-Positive T-Lymphocytes metabolism
Carcinoma, Non-Small-Cell Lung etiology
Lung Neoplasms etiology
Lymphocytes, Tumor-Infiltrating metabolism
Programmed Cell Death 1 Receptor genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1664-3224
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in immunology
- Publication Type :
- Academic Journal
- Accession number :
- 34122444
- Full Text :
- https://doi.org/10.3389/fimmu.2021.680973